Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Clinical Investigation
An Early and Complete Reperfusion Strategy for Acute Myocardial Infarction Using Fibrinolysis and Subsequent Transluminal Therapy
The FAST Trial
Ken NagaoNariyuki HayashiKatsuo KanmatsuseSatoru KikuchiTomiya OhubaHiroshi Takahashi
Author information
JOURNAL FREE ACCESS

2002 Volume 66 Issue 6 Pages 576-582

Details
Abstract

The efficacy and safety of fibrinolysis and subsequent transluminal (FAST) therapy were evaluated in 195 patients with acute myocardial infarction (AMI) for the early achievement of thrombolysis-in-myocardial-infarction grade 3 (TIMI-3) flow in the infarct-related artery. Intravenous thrombolysis using the optimal dose of a thrombolytic agent was initiated immediately after arrival in the emergency room, followed by coronary angiography and adjuvant percutaneous coronary intervention. A comparison of the thrombolysis alone (n=83) and thrombolysis plus intervention (n=112) groups showed significant differences in the time interval from hospital arrival to achievement of TIMI-3 flow (66.2±23.7 vs 111.6 ±29.6 min, p<0.0001), creatine kinase-MB release (295 ±201 vs 468±322 U/L, p=0.0003) and peak troponin T (23.6±16.9 vs 38.9±25.9 ng/ml, p<0.0001). No significant differences were observed in either 30-day mortality or complications. The TIMI-3 flow at the initial angiography was significantly higher with a single bolus of mutant tissue-type plasminogen activator (t-PA) monteplase than with an accelerated infusion of t-PA (60% vs 32%, p=0.005). In conclusion, the early restoration of TIMI-3 flow by FAST therapy reduced the degree of myocardial damage with a low risk of complications. TIMI-3 flow was achieved at an earlier stage with monteplase and this agent may be beneficial in the FAST therapy. (Circ J 2002; 66: 576 - 582)

Content from these authors
© 2002 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top